Format

Send to

Choose Destination
J Dermatol. 2015 Aug;42(8):778-85. doi: 10.1111/1346-8138.12922. Epub 2015 May 18.

Use of procalcitonin, C-reactive protein and white blood cell count to distinguish between lower limb erysipelas and deep vein thrombosis in the emergency department: A prospective observational study.

Author information

1
University Department of Internal Medicine, Kantonsspital Aarau, Aarau, Switzerland.
2
University Clinic of Infectious Diseases, University Hospital Bern, Bern, Switzerland.
3
Division of Infectious Diseases, University Department of Internal Medicine, Kantonsspital Aarau, Aarau, Switzerland.
4
Department of Laboratory Medicine, Kantonsspital Aarau, Aarau , Switzerland.

Abstract

Early differentiation of erysipelas from deep vein thrombosis (DVT) based solely on clinical signs and symptoms is challenging. There is a lack of data regarding the usefulness of the inflammatory biomarkers procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) count in the diagnosis of localized cutaneous infections. Herein, we investigated the diagnostic value of inflammatory markers in a prospective at-risk patient population. This is an observational quality control study including consecutive patients presenting with a final diagnosis of either erysipelas or DVT. The association of PCT (μg/L) and CRP (mg/L) levels and WBC counts (g/L) with the primary outcome was assessed using logistic regression models with area under the receiver-operator curve. Forty-eight patients (erysipelas, n = 31; DVT, n = 17) were included. Compared with patients with DVT, those with erysipelas had significantly higher PCT concentrations. No significant differences in CRP concentrations and WBC counts were found between the two groups. At a PCT threshold of 0.1 μg/L or more, specificity and positive predictive values (PPV) for erysipelas were 82.4% and 85.7%, respectively, and increased to 100% and 100% at a threshold of more than 0.25 μg/L. Levels of PCT also correlated with the severity of erysipelas, with a stepwise increase according to systemic inflammatory response syndrome criteria. We found a high discriminatory value of PCT for differentiation between erysipelas and DVT, in contrast to other commonly used inflammatory biomarkers. Whether the use of PCT levels for early differentiation of erysipelas from DVT reduces unnecessary antibiotic exposure needs to be assessed in an interventional trial.

KEYWORDS:

cellulitis; deep vein thrombosis; erysipelas; lower limb; procalcitonin

PMID:
25982244
DOI:
10.1111/1346-8138.12922
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center